Sroll To Bottom
Latest news
30
Apr

2026

Clinical Trial Vanguard: The Disease-Modification Bet in Pulmonary Arterial Hypertension
30
Apr

2026

Drug Development & Delivery: Affibody Molecules; A Versatile Approach to Radiopharma
28
Apr

2026

Dicot Pharma intends to carry out an 80% already secured rights issue of SEK 210 million

Our services are thoughtfully crafted and constantly evolving to help achieve your goals

See us at...
We will be attending
04
May
Swiss Biotech Day, Basel
4-6 May 2026
11
May
ASGCT, Boston
11-15 May 2026
19
May
LSX Nordic Congress, Copenhagen
19-20 May 2026
Testimonials